Literature DB >> 22528271

Accessing a small library of pluripotent 1,4,5-trisubstituted 1H-1,2,3-triazoles via diversity-oriented synthesis.

Arya Ajay1, Munna Prasad Gupt, N Devender, Rama P Tripathi.   

Abstract

Diversity-oriented synthesis of structurally different, novel and small drug like molecules based on 1,4,5-trisubstituted 1,2,3-triazoles is developed in a streamlined sequence of different sets of reactions. The method involves the use of simple, readily available and highly economical substrates and reagents. The molecules developed herein have potential to be exploited either as chemotherapeutic agents or as scaffolds for other biologically active compounds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528271     DOI: 10.1007/s11030-012-9369-y

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  27 in total

Review 1.  Target-oriented and diversity-oriented organic synthesis in drug discovery.

Authors:  S L Schreiber
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

2.  Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

Authors:  Louise Domeneghini Chiaradia; Alessandra Mascarello; Marcela Purificação; Javier Vernal; Marlon Norberto Sechini Cordeiro; María Emilia Zenteno; Andréa Villarino; Ricardo José Nunes; Rosendo Augusto Yunes; Hernán Terenzi
Journal:  Bioorg Med Chem Lett       Date:  2008-10-05       Impact factor: 2.823

3.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

Authors:  A Ajay; W P Walters; M A Murcko
Journal:  J Med Chem       Date:  1998-08-27       Impact factor: 7.446

4.  Solid-phase synthesis and chemical space analysis of a 190-membered alkaloid/terpenoid-like library.

Authors:  Gustavo Moura-Letts; Christine M Diblasi; Renato A Bauer; Derek S Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-30       Impact factor: 11.205

5.  Regioselective [3+2] cycloaddition of chalcones with a sugar azide: easy access to 1-(5-deoxy-D-xylofuranos-5-yl)-4,5-disubstituted-1H-1,2,3-triazoles.

Authors:  Nimisha Singh; S K Pandey; Rama P Tripathi
Journal:  Carbohydr Res       Date:  2010-04-24       Impact factor: 2.104

6.  Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives.

Authors:  H J Wadsworth; S M Jenkins; B S Orlek; F Cassidy; M S Clark; F Brown; G J Riley; D Graves; J Hawkins; C B Naylor
Journal:  J Med Chem       Date:  1992-04-03       Impact factor: 7.446

7.  Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates.

Authors:  Fahmi Himo; Timothy Lovell; Robert Hilgraf; Vsevolod V Rostovtsev; Louis Noodleman; K Barry Sharpless; Valery V Fokin
Journal:  J Am Chem Soc       Date:  2005-01-12       Impact factor: 15.419

8.  Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles.

Authors:  Stanislav A Bakunov; Svetlana M Bakunova; Tanja Wenzler; Maedot Ghebru; Karl A Werbovetz; Reto Brun; Richard R Tidwell
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

9.  Synthesis of triazoles from nonactivated terminal alkynes via the three-component coupling reaction using a Pd(0)-Cu(I) bimetallic catalyst.

Authors:  Shin Kamijo; Tienan Jin; Zhibao Huo; Yoshinori Yamamoto
Journal:  J Am Chem Soc       Date:  2003-07-02       Impact factor: 15.419

10.  Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors.

Authors:  Alexander Adibekian; Brent R Martin; Chu Wang; Ku-Lung Hsu; Daniel A Bachovchin; Sherry Niessen; Heather Hoover; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2011-05-15       Impact factor: 15.040

View more
  1 in total

1.  Molecular modeling and design of some β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives against chloroquine sensitive, 3D7 strain of Plasmodium falciparum.

Authors:  Zakari Ya'u Ibrahim; Adamu Uzairu; Gideon Adamu Shallangwa; Stephen Eyije Abechi
Journal:  Heliyon       Date:  2021-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.